Abstract: A light source module includes a circuit substrate, a plurality of light-emitting diodes, a cover layer and a plurality of first scattering particles. The plurality of light-emitting diodes is disposed on the circuit substrate. The cover layer covers the plurality of light-emitting diodes, and an upper surface of the cover layer has a plurality of recesses, wherein orthogonal projections of the plurality of recesses on the circuit substrate overlap the circuit substrate between the plurality of light-emitting diodes. The plurality of first scattering particles is located in the plurality of recesses.

Abstract: An electronic apparatus for establishing prediction model based on electroencephalogram (EEG). The electronic apparatus is configured for: acquiring an EEG signal segment related to an epilepsy patient; dividing each EEG signal into EEG components according to a predetermined window size; retrieving datasets corresponding to EEG features from the EEG components of each EEG signal segment; acquiring statistical feature values of each dataset of each EEG signal segment; determining a gain ratio of each of the statistical feature values of each EEG signal segment based on the statistical feature values corresponding to each of the EEG features; selecting specific statistical feature values from the statistical feature values according to the gain ratio of each of the statistical feature values of each EEG signal segment; establishing a prediction model based on the specific statistical feature values of the epilepsy patient.

Abstract: The present invention relates to the newly identified cancer therapeutic targets and biomarkers. These targets/biomarkers are overexpressed in carcinomas generally, and more specifically to adenocarcinoma and squamous cell carcinoma. The invention provides methods of diagnosis, characterization, and therapy of carcinoma based on the degree of overexpression of the targets/biomarkers.

Abstract: The present invention relates to the newly identified cancer therapeutic targets and biomarkers. These targets/biomarkers are overexpressed in carcinomas generally, and more specifically to adenocarcinoma and squamous cell carcinoma. The invention provides methods of diagnosis, characterization, and therapy of carcinoma based on the degree of overexpression of the targets/biomarkers.

Abstract: The present invention relates to the newly identified cancer therapeutic targets and biomarkers. These targets/biomarkers are overexpressed in carcinomas generally, and more specifically to adenocarcinoma and squamous cell carcinoma. The invention provides methods of diagnosis, characterization, and therapy of carcinoma based on the degree of overexpression of the targets/biomarkers.